BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36814205)

  • 1. The balance between lung regulatory T cells and Th17 cells is a risk indicator for the acute exacerbation of interstitial lung disease after surgery: a case-control study.
    Fukui M; Harada N; Takamochi K; Hayashi T; Matsunaga T; Hattori A; Kawagoe I; Suzuki K
    BMC Pulm Med; 2023 Feb; 23(1):70. PubMed ID: 36814205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
    Ishikawa G; Acquah SO; Salvatore M; Padilla ML
    Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Th1 Cells and Increased Th2 Cells in Peripheral Blood Are Associated with Idiopathic Inflammatory Myopathies Patients with Interstitial Lung Disease.
    Cheng L; Li Y; Luo Y; Zhou Y; Wen J; Wu Y; Liang X; Wu T; Tan C; Liu Y
    Inflammation; 2023 Feb; 46(1):468-479. PubMed ID: 36264424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.
    Ozawa Y; Shibamoto Y; Hiroshima M; Nakagawa M; Ono A; Hanaoka R; Yamamoto A; Tominaga J; Kawada H; Koyama M; Takumi K; Tsubakimoto M; Egashira R; Tsushima F; Kikuchi Y; Izumi Y; Ushio T; Kimura M; Ichikawa S; Kitamura N; Matsushita S; Okauchi K; O'uchi T; Ishikawa H; Kitase M
    AJR Am J Roentgenol; 2021 Oct; 217(4):859-869. PubMed ID: 33852356
    [No Abstract]   [Full Text] [Related]  

  • 10. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
    Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
    J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell immunity in interstitial lung disease with non-small cell lung cancer patients.
    Isono T; Iwahori K; Yanagawa M; Yamamoto Y; Tone M; Haruna M; Hirata M; Fukui E; Kimura T; Kanou T; Ose N; Funaki S; Takeda Y; Morii E; Kumanogoh A; Shintani Y; Wada H
    Lung Cancer; 2023 Aug; 182():107278. PubMed ID: 37321075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
    Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
    Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.
    Kato M; Yamada T; Kataoka S; Arai Y; Miura K; Ochi Y; Ihara H; Koyama R; Sasaki S; Takahashi K
    Respir Res; 2019 Dec; 20(1):287. PubMed ID: 31852459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between preoperative
    Oishi H; Sakurada A; Notsuda H; Tanaka R; Takanami K; Saito R; Eba S; Noda M; Okada Y
    Respir Investig; 2021 Jan; 59(1):106-113. PubMed ID: 33004286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review.
    Chida M; Kobayashi S; Karube Y; Hayama M; Tamura M; Ishihama H; Oyaizu T
    Ann Thorac Cardiovasc Surg; 2012; 18(4):314-7. PubMed ID: 22446955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease.
    Hagiwara Y; Nakayama Y; Kudo S; Hayakawa T; Nakamura N; Kitamoto Y; Takahashi S; Tsujino K; Kubo N; Tamaki Y; Nagata Y;
    J Radiat Res; 2020 Jul; 61(4):563-574. PubMed ID: 32363376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
    Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
    Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.